Research Team

Matthew L. Kaplan

Managing Director, Head of Healthcare Equity Research

mkaplan@ladenburg.com

Mr. Kaplan has 14 years of experience as a biotechnology analyst. His current research focus is therapeutic companies, cardiovascular, and drug delivery. Prior to joining Ladenburg Thalmann, he was a Partner and the Director of Healthcare Research with Punk, Ziegel & Company. Previously, he was a Senior Biotechnology Analyst at Evolution Capital and a Director of The Life Sciences Group at The Carson Group. Before joining The Carson Group and Evolution Capital, Mr. Kaplan had six years of experience as a Research Associate with the Albert Einstein College of Medicine/Montefiore Hospital Department of Cardiology. Mr. Kaplan received his bachelor’s degree in Biology from the University of Michigan and studied Cellular and Molecular Biology at Columbia University.

Healthcare & Life Sciences

Matthew L. Kaplan

Matthew L. Kaplan

Managing Director, Head of Healthcare Equity Research

Jeffrey S. Cohen

Jeffrey S. Cohen

Managing Director, Equity Research

Wangzhi Li, PhD

Wangzhi Li, PhD

Managing Director, Equity Research-Biotech

Michael J. Higgins

Michael J. Higgins

Managing Director, Senior Biopharmaceuticals Equity Research

Yield-Oriented Equities

Mickey M. Schleien, CFA

Mickey M. Schleien, CFA

Managing Director, Equity Research

Christopher Nolan, CFA

Christopher Nolan, CFA

Executive Vice President, Equity Research

Energy, Power & Infrastructure

Michael C. Schmitz, CFA

Michael C. Schmitz, CFA

Managing Director, Equity Research

Telecom, Media & Technology

Jon R. Hickman

Jon R. Hickman

Managing Director, Equity Research

Glenn G. Mattson, Jr.

Glenn G. Mattson, Jr.

Vice President, Equity Research